The battle against meningococcal disease, a potentially life-threatening bacterial infection, is gaining momentum with the increasing use of vaccines. The global Meningococcal Vaccines Market is experiencing a surge, driven by rising disease incidence worldwide. Currently valued at an estimated USD 3.95 billion in 2024, the market is projected to reach a staggering USD 9.014 billion …
Tag Archives: Meningococcal Vaccines Market
Global Meningococcal Vaccines Industry is expected to grow at an 8.6% CAGR and reach a benchmark of US$ 7.7 Billion by 2032 | FMI analysis
The Global Meningococcal Vaccines Industry is poised for significant expansion, according to a recent report by Future Market Insights (FMI), a leading market research firm. The market is projected to achieve a robust Compound Annual Growth Rate (CAGR) of 8.6% over the forecast period, reaching a substantial valuation of US$3.4 billion by 2022. In a …
Meningococcal Meningitis Treatment Market to Grow at 4.7% CAGR, Crossing US$ 283 Million by 2033 | FMI
The global Meningococcal Meningitis Treatment Market has a market value of US$ 170.75 Million in 2022 and is predicted to have a market value of US$ 283 Million by 2023 to 2033, at a CAGR of 4.7%. Meningococcal Meningitis treatment market growth can be attributable to illness prevalence, increased vaccine availability, and increased disease awareness. From …
Meningococcal VaccinesStrengthening Global Health: Meningococcal Vaccines Market Predicted to Skyrocket to US$ 7.7 Billion by 2032, Fueled by Strong 8.6% CAGR Expansion
Over the forecast period, the market for Meningococcal Vaccines is anticipated to grow at a CAGR of 8.6%, reaching US$ 3.4 Bn in 2022. According to Future Market Insights (FMI), the conjugate vaccines segment held a 62.6% revenue share of the market in 2021. The global meningococcal vaccines market is expected to grow at an 8.6% CAGR during …